Companies › ONC
BEONE MEDICINES LTD (ONC)
Institutional ownership, SEC filings and insider activity
Sector: Healthcare & Pharma · SEC CIK 0001651308 · EDGAR filings · Updated 2026-07-24
BEONE MEDICINES LTD (ONC) has reported institutional ownership of 2.4%, with 279 institutional managers holding positions valued at $10.3B per the latest 13F reporting period.
Filings this week (3)
- 2026-07-24 — Insider transaction reported (Form 4)
- 2026-07-22 — Insider transaction reported (Form 4)
- 2026-07-22 — Notice of proposed sale filed (Form 144)
Every filing links to the official SEC document. Real-time filing alerts for this company are available inside the app.
Latest updates
- 2026-07-17 — Insider transaction reported (Form 4)
- 2026-07-17 — Insider transaction reported (Form 4)
- 2026-07-14 — Insider transaction reported (Form 4)
Institutional ownership overview
According to SEC 13F filings tracked by Sightfile, BEONE MEDICINES LTD has 279 institutional holders and institutional ownership of 2.4%.
Insider activity
Insiders reported 224 transactions (0 buys, 153 sells) across 15 reporting insiders, with a net reported value of −$150.8M.
Related companies
EXELIXIS INC (EXEL) · ENSIGN GROUP INC (ENSG) · BIOMARIN PHARMACEUTICAL INC (BMRN) · REVVITY INC (RVTY) · SANOFI SA (SNY) · CYTOKINETICS INC (CYTK)
See full history, cross-references and alerts on SightfileData sources: SEC EDGAR (filings, 13F, FTD), aggregated by Sightfile. Page updated 2026-07-24.